Chengzhi Shareholding Co.,Ltd Company Profile

08:55 EDT 17th March 2018 | BioPortfolio

Chengzhi Shareholding Co.,Ltd was established on October 8. 1998 in Nanchang, Currently the total asset is 922.18 millions Yuan with 27 subsidiary companies. The company currently has more than 1900 employees with support from Tsinghua University and with several tens of professors, doctors, and masters as backbone, a team of high standard scientific research and management team is driving the ever changing operation of Chengzhi.

Chengzhi Life Science Co.,Ltd in Beijing for biochemical and fine chemical product business, as the subordinate of Chengzhi Shareholding Co.,Ltd., is a medium-sized enterprise which its registration capital is RMB180 million.

As a subsidiary factory of Chengzhi Life Science Co.,Ltd, Jiangxi Chengzhi Bioengineering Company Ltd is located in Jiangxi Province. It occupies an area of 22000m2 with a building area of 15000m2. The factory is built according to the GMP standard, commercial production is carried out in plant operating to ISO 9001:2000 and Koshier by Orthodox Union. The development and production of the L-Glutamine and D-Ribose are in the first place in China.

We have two series main product produced in several chengzhi’s plants routinely. L-Glutamine and D-Ribose, manufactured by Jiangxi Chengzhi Bioengineering Company Ltd , are very popular in international market. The fluorescent brighteners series and fine chemical intermediates series, manufactured by chengzhi’s other chemical plants, are also competitive both at price and quality compare with the other suppliers.


805C#, Dongsheng Plaza B, NO.8 Zhongguancun East Road, Haidian Dist,


Phone: 86-10-82526466
Fax: 86-10-82526963

News Articles [14 Associated News Articles listed on BioPortfolio]

Bioventix Plc - Director/PDMR Shareholding

PR NewswireLondon, October 20 Bioventix plc ("Bioventix' or the "Company') Director/PDMR Shareholding Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of .....

LCT to sell JV shares for $3 million and receive Diabecell licence

New Zealand-based Living Cell Technologies has agreed to sell its 50% shareholding in joint venture company,…

TiGenix: JPMorgan Chase & Co notifies 3.12% shareholding in TiGenix

Leuven (Belgium) - November 24, 2017, 22:00h CEST -TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") publishes today a transparency notification pursuant to Article 14 of the Belgian Law o...

Shire plc: Director/PDMR Shareholding

Director/PDMR ShareholdingMarch 12, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG)Notification of transactions by persons discharging managerial responsibilities+--+------------------------------------...

Pfizer Sells Stake in Chinese JV with Hisun

US pharmaceutical giant Pfizer has divested its 49% stake in Hisun-Pfizer Pharmaceuticals its Chinese joint venture with Zhejiang Hisun Pharma. As part of the plan, Sapphire I Holdings, which is indir...

Bayer Divests More of Covestro

As it works toward unloading all of its shareholding in its former plastics subsidiary Covestro – the former Bayer MaterialScience – the Bayer group said it has begun an accelerated bookbu...

Saudi Binladin Group denies govt takeover after chief detained

Saudi construction giant Binladin Group denied Saturday any state takeover after its chairman was detained, but said some shares may have been transferred to the government. The firm, which has been ...

News Release: Capital Increase Reserved for employees outside France

Capital Increase Reserved for employees outside France PDF Version of the news release Charenton-le-Pont, France (October 26, 2017 - 8:00 a.m.) - Essilor International SA announ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [6 Associated Companies listed on BioPortfolio]

Chengzhi Shareholding Co.,Ltd

Chengzhi Shareholding Co.,Ltd was established on October 8. 1998 in Nanchang, Currently the total asset is 922.18 millions Yuan with 27 subsidiary companies. The company currently has more than 1900 e...

Cool Logistics Ltd

Cool Logistics is based in the UK and is focused on delivering temperature controlled packaging throughout Europe. We have manufacturing facilities in several European countries and are ISO Certified....

Tridelta plc

Tridelta plc is the Parent Company of Tridelta Development Limited, which specialises in the Research, Development, Manufacturing and Marketing of Diagnostic Products for application principally withi...


The NOACK Group of Companies was founded in 1980 as NOACK SA. in Ascona, Switzerland, by Mr. Dieter Noack. The main focus was distribution of products into the feed and agrofood industries.Starting fr...

Dalian Chemphy Chemical Co.,Ltd

Dalian Chemphy Chemical Co., Ltd. (Chemphy) is a technology-based shareholding enterprise invested by Dalian Institute of Chemical Physics (DICP, affiliated to Chinese Academy of Sciences), Dalian Jin...

More Information about "Chengzhi Shareholding Co.,Ltd" on BioPortfolio

We have published hundreds of Chengzhi Shareholding Co.,Ltd news stories on BioPortfolio along with dozens of Chengzhi Shareholding Co.,Ltd Clinical Trials and PubMed Articles about Chengzhi Shareholding Co.,Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chengzhi Shareholding Co.,Ltd Companies in our database. You can also find out about relevant Chengzhi Shareholding Co.,Ltd Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record